Vendor, Graz, AUT
Research Center Pharmaceutical Engineering GMBH
UEI JMW6R9VB27L9, CAGE 5831N
1 award and $733,525 obligated between September 4, 2026 and September 4, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $733,525 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126C00098Definitive Contract, September 4, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Next Generation Process Development and Quality Control in Protein Lyophilization Using Mechanistic and AI ApproachesNAICS 541714, PSC AN11 | $733,525 |
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards